CD274 and neoplasm: Potent, antigen-specific cytotoxicity against both MSTOMSLN and MSTOMSLN-PD-L1 was observed for all three TRuC-T cell products, with no observable differences in tumor lysis, irrespective of PD-L1 expression by the target cells (Fig. 2a).